A detailed history of Farther Finance Advisors, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 13 shares of FLGT stock, worth $238. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 13 -0.0%
Holding current value
$238
Previous $261,000 8.05%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $23 - $30
1 Added 7.69%
14 $405,000
Q1 2023

May 13, 2024

SELL
$29.39 - $36.27 $29 - $36
-1 Reduced 7.14%
13 $406,000
Q1 2023

Sep 12, 2023

SELL
$29.39 - $36.27 $4,614 - $5,694
-157 Reduced 92.35%
13 $406,000
Q4 2022

Sep 11, 2023

BUY
$29.23 - $40.28 $4,969 - $6,847
170 New
170 $5.06 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $555M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.